Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease
- 5 May 2015
- journal article
- review article
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 19 (5) , 436-440
Abstract
Patients with chronic kidney disease (CKD) frequently have mineral and bone disorders (CKD‐MBD) that are caused by several mechanisms. Recent research has suggested that uremic toxins from the gut such as p‐cresyl sulfate (PCS) and indoxyl sulfate (IS) could also be involved in the development of bone disease in patients with CKD. IS and PCS are produced by microbiota in the gut, carried into the plasma bound to serum albumin, and are normally excreted into the urine. However, in patients with CKD, there is an accumulation of high levels of these uremic toxins. The exact mechanisms of action of uremic toxins in bone disease remain unclear. The purpose of this brief review is to discuss the link between uremic toxins (IS and PCS) and bone mineral disease in chronic kidney disease.Keywords
This publication has 36 references indexed in Scilit:
- Association of Indoxyl Sulfate With Fibroblast Growth Factor 23 in Patients With Advanced Chronic Kidney DiseaseThe American Journal of the Medical Sciences, 2014
- Indoxyl sulfate promotes apoptosis in cultured osteoblast cellsBMC Pharmacology and Toxicology, 2013
- Uremic osteoporosisKidney International Supplements, 2013
- Mineral Metabolic Abnormalities and Mortality in Dialysis PatientsNutrients, 2013
- Role of Uremic Toxins and Oxidative Stress in the Development of Chronic Kidney Disease–Mineral and Bone DisorderJournal of Renal Nutrition, 2012
- Indoxyl sulphate inhibits osteoclast differentiation and functionNephrology Dialysis Transplantation, 2011
- Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney diseaseBone, 2011
- Role of Oxidative Stress and Indoxyl Sulfate in Progression of Cardiovascular Disease in Chronic Kidney DiseaseTherapeutic Apheresis and Dialysis, 2011
- Low Bone Mineral Density and Fractures in Long-Term Hemodialysis Patients: A Meta-AnalysisAmerican Journal of Kidney Diseases, 2007
- Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)Kidney International, 2006